Ironwood Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Hold
4,500
0.03% 243
2026
Q1
$273K Buy
4,500
+221
+5% +$12.9K 0.04% 228
2025
Q4
$231K Sell
4,279
-254
-6% -$12.2K 0.03% 247
2025
Q3
$204K Sell
4,533
-134
-3% -$6.26K 0.03% 255
2025
Q2
$216K Buy
4,667
+96
+2% +$4.71K 0.03% 240
2025
Q1
$279K Sell
4,571
-262
-5% -$15.3K 0.05% 205
2024
Q4
$273K Sell
4,833
-97
-2% -$5.42K 0.05% 213
2024
Q3
$255K Hold
4,930
0.04% 227
2024
Q2
$205K Hold
4,930
0.04% 246
2024
Q1
$267K Hold
4,930
0.05% 224
2023
Q4
$253K Buy
+4,930
New +$259K 0.05% 216
2016
Q3
Sell
-5,560
Closed -$409K 146
2016
Q2
$409K Sell
5,560
-300
-5% -$21.2K 0.24% 88
2016
Q1
$374K Hold
5,860
0.2% 94
2015
Q4
$403K Buy
5,860
+200
+4% +$13.2K 0.23% 88
2015
Q3
$335K Buy
5,660
+100
+2% +$6.34K 0.18% 96
2015
Q2
$370K Hold
5,560
0.19% 95
2015
Q1
$359K Hold
5,560
0.18% 100
2014
Q4
$328K Buy
+5,560
New +$314K 0.17% 104

Other funds holding BMY

Ironwood Investment Counsel's BMY Position: Q2 2026 in Review

Ironwood Investment Counsel held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 4,500 shares worth $259K. The position accounts for 0.03% of the portfolio, ranked #243.

Ironwood Investment Counsel first reported a position in BMY in Q4 2014 and has held it in 18 quarters since. The position peaked at $409K in Q2 2016. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Ironwood Investment Counsel held 4,500 shares of Bristol-Myers Squibb worth $259K as of Q2 2026.
  • Ironwood Investment Counsel left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.03% of Ironwood Investment Counsel's portfolio in Q2 2026, its #243 holding.
  • Ironwood Investment Counsel first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 18 quarters since.
  • Ironwood Investment Counsel's Bristol-Myers Squibb position peaked at $409K in Q2 2016.
  • 1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Ironwood Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.